Respiratory Diseases/Disorders

Perrigo Starts Shipment of Generic Mucinex

Perrigo has begun shipment of Guaifenesin, the generic version of Reckitt Benckiser’s Mucinex. The extended-release tablets are an expectorant indicated to relieve chest congestion and make coughs more productive.

Mylan Launches Generic Xopenex Inhalation Solution

Mylan received final FDA approval for Levalbuterol Inhalation Solution. A generic version of Sunovion’s Xopenex, the beta-2 agonist treats bronchospasms in patients older than 6 years of age with reversible obstructive airway disease.

Phase 3 Study Results Announced for Omalizumab in CIU

Genentech and Novartis announced the results from a Phase 3 study, ASTERIA II, which showed that omalizumab, met its primary endpoint in patients with moderate to severe chronic idiopathic urticaria (CIU), who remained symptomatic despite treatment with approved H1 antihistamine doses.